USD 4.97 billion
Tissue Diagnostics Market Size, Share, Growth Analysis, By Product(Consumables, and Instruments), By Technology(Immunohistochemistry, In-situ Hybridization, Digital Pathology & Workflow Management, and Special Staining), By Disease Type(Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer), By End User(Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35H2161 |
Region:
Global |
Published Date: September, 2024
Pages:
242
|Tables:
94
|Figures:
76
Tissue Diagnostics Market Insights
Tissue Diagnostics Market size was valued at USD 5.3 Billion in 2023 and is poised to grow from USD 5.65 Billion in 2024 to USD 10.04 Billion by 2032, growing at a CAGR of 6.6% during the forecast period (2025-2032).
The tissue diagnostics market is expected to gain strong growth opportunities during the forecast period. This growth is due to the increasing prevalence of cancer. COVID-19 has impacted the tissue diagnostics industry primarily. Diagnostic testing was significantly slowed down during the pandemic as there was a focus on containing the virus within medical resources. Routine medical processes are affected during the period. During the epidemic, the need for tissue diagnostics services and products went low temporarily. However, when things started becoming better and healthcare systems began adjusting to the new norm, the market again started to bounce up. The post-pandemic world was characterized by a continued high requirement for a precise diagnosis and monitoring of several diseases, among which cancer was included. Considering the rapid increase in cancer incidence, anatomic pathology is changing fast. That again promotes the continuous expansion of the clinical pathology domain. The anatomical and molecular pathology domain are converging constantly. More often, liquid biopsies are utilized for the diagnosis of cancer. As computational pathology has started gaining momentum, it becomes increasingly important for bioinformatics and analytics integration. The tissue diagnostics sector has, over the past 20 years, witnessed the availability of increasingly sophisticated equipment, transforming the lives of pathologists and clinical practitioners altogether.
US Tissue Diagnostics Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
Consumables
Fastest Growth
Immunohistochemistry
Growth Rate
6.6% CAGR
Global Tissue Diagnostics Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Tissue Diagnostics Market Segmental Analysis
Global Tissue Diagnostics Market is segmented on the basis of product, technology, disease type, end user, and region. By product, market is segmented into consumables, and instruments. By technology, market is segmented into immunohistochemistry, in situ hybridization, digital pathology & workflow management, and special staining. By disease type, market is segmented into breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung cancer, and other disease types. By end user, market is segmented into hospitals, research laboratories, pharmaceutical companies, contract research organizations, and other end users. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Tissue Diagnostics Market
Analysis by Technology
The tissue diagnostics market has developed the most crucial application in the hands of immunohistochemistry, accounting for the highest revenue share 2023. The effectiveness of IHC can be understood from its wide usage in clinical research and the range of applications in developing various cancer diagnostics and treatments. The technique is increasingly being seen as a replacement for traditional methods of enzyme staining since it can reveal slight differences existing between various forms of tumors, which makes diagnosis highly accurate. Conventional methods are limited in identifying proteins, enzymes, and structural components of cancerous tissues as opposed to the variability of specific biomarkers IHC offers regarding several types of cancers. The Tissue Diagnostics Market is growing as specificity associated with the product not only helps in focused therapy development but also improves the accuracy of diagnoses.
The highest CAGR for the projection period is expected for digital pathology and workflow. Increased use of whole-slide imaging by pathologists is driving higher sector growth and application growth. To improve the detection of cancer and provide clinically informative measurements of tumors, WSI extracts certain features from tumors and measures every aspect of these characteristics. Leaders in the Tissue Diagnostics Market are employing strategic moves to widen the spectrum of products being supplied. As an instance, in September 2021, Roche launched Digital Pathology Open Environment, which enables developers of image analysis software to easily connect their tools and image analysis solutions with Roche's corporate uPath software for tumor tissue.
Analysis by Disease Type
The breast cancer segment led the tissue diagnostics market. Breast cancer is a significant global health issue, and tissue diagnostics forms an essential component in the identification, diagnosis, and planning of treatment for breast cancer. Samples of breast tissue are increasingly analyzed by advanced methods such as in situ hybridization and immunohistochemistry to achieve an accurate characterization of cancers. The demand for tissue diagnostics services and solutions specifically designed for the detection and treatment of breast cancer has increased due to this development. Various research projects undertaken in collaboration with the funding provided by public and commercial institutions propel the generation of efficient solutions for breast cancer diagnostics, thus propelling the growth of the market based on this application.
The gastric cancer segment of the tissue diagnostics market is expected to witness high growth during the forecast period. This is because stomach cancer has a high incidence rate globally, particularly in high-prevalence regions such as East Asia and Latin America. With the help of advanced technology in diagnosis through molecular profiling and immunohistochemistry, better patient outcome is possible along with early intervention. Increased awareness of the necessity for early diagnosis and routine screening also encourages better-informed healthcare professionals to go for sophisticated tissue diagnostics solutions. Gastric cancer has all the bases covered to be a bright performer in tissue diagnostics, riding on the discovery of novel biomarkers and targets for treatment.
Global Tissue Diagnostics Market By Disease Type
To get detailed analysis on other segments, Request For Free Sample Report
Tissue Diagnostics Market Regional Insights
The Tissue Diagnostics Market share of North America is major due to the high incidence rate of cancer. Some public efforts are being made towards reducing cancer cases and consequently increasing demand for cancer diagnostics in the local market. The main cancer prevention and control research network by the Centers for Disease Control and Prevention is on cancer prevention in this region. Next, human tissue is an important area for new test development for personalized medicine. Personalized medicine has been greatly expanded by the increased utilization of the sequencing technologies and healthcare IT systems in clinical workflow, which have turned out to increase the utilization of tissue diagnostics. The United States' Precision Medicine Initiative adds to the continued expansion of the customized medicine sector in North America.
However, Asia-Pacific is predicted to grow at a profitable pace over the projection period with increased accessibility to diverse tissue diagnostic tests by multinational firms. The collaborations targeted to boost the region's capacity for diagnostics help sustain this growth. For instance, Hamamatsu Photonics K.K. and Indica Labs announced their agreement to cooperate in perfecting integrated digital pathology processes, with a view to improving access to advanced diagnostic technologies among healthcare professionals. This collaboration illustrates how the sector can embrace the use of advanced technology to speed up and improve accuracy in tissue diagnostics, which in turn should lead to better patient outcomes.
Global Tissue Diagnostics Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Tissue Diagnostics Market Dynamics
Tissue Diagnostics Market Drivers
Growing Prevalence of Chronic Illnesses
- One major growth driver in the growth of the tissue diagnostics market is the increasing prevalence of chronic diseases, especially cancer. Despite the growing international rates of cancer, fast and accurate diagnostic solutions are vital as they offer a chance to undergo successful treatment if these diseases are diagnosed in their preliminary stages. Advances in tissue diagnostics technology include immunohistochemistry and molecular pathology. Given these advances, medical practitioners have determined the types of tumors and their subtypes. The various pressures being brought in to ascertain accurate diagnostic tools are forcing healthcare providers to invest in advanced tissue diagnostics technologies. This contributes to the growth of the market and improvement in cancer patients' care.
Advancements in Technology
- Technological advancements in diagnostic techniques are revolutionizing the tissue diagnostics market. Automated scanning of slides through digital pathology and advanced imaging technologies enhances the precision and effectiveness of tissue analysis. They help in better turn-around time towards improving capabilities for diagnosing, thus further aiding pathologists in findings interpretation. Moreover, with artificial intelligence, if integrated into tissue diagnostics, processes are becoming more streamlined while the accuracy of diagnosis is being improved. Furthermore, such advanced technologies that involve procedures such as tissue diagnostics lead the medical fraternity to extend the market to a considerable size as healthcare providers need to reduce the chances of errors and enhance patient care.
Restraints
High Cost of Advanced Diagnostics
- Modern tissue diagnostics is of high cost, which is a critical restraint for the industry. Newer techniques and diagnostic tools may be quite expensive for smaller hospitals and laboratories. Indeed, these diagnostic techniques can be prohibitive due to the high equipment costs, training, and maintenance costs. The cost can be a limitation to the availability of updated diagnostic tests, especially in developing countries with unavailability of healthcare resources. This may slow the adoption of advanced tissue diagnostics in some regions and may restrict the availability of precise diagnostic tools for patients, thereby slowing the overall Tissue Diagnostics Market growth.
Regulatory Hurdles
- Regulatory challenges may slow down the growth of the tissue diagnostics market because it becomes challenging to navigate the complexity of regulatory procedures that may delay the release of new technologies. There is a need for exhaustive record-keeping and strict regulations by the regulatory agencies for the diagnostic products to be safe and effective. This would probably translate to more extended timescales in product development and entry into the marketplace, a factor that makes businesses shy away from investing with an aim of changing the course of tissue diagnostics. Regional variations in the regulations, however, would again restrict further prospects on the market as such regulations may add even more complexity to the global market plans of firms.
Request Free Customization of this report to help us to meet your business objectives.
Tissue Diagnostics Market Competitive Landscape
The global tissue diagnostics market is relatively saturated with the presence of very few big players across the globe such as Abbott Laboratories, Danaher Corporation, Agilent Technologies. A significant amount of money is being invested in the R&D sector by the companies to increase their product portfolio and consolidate themselves in the market. Apart from this, partnerships, acquisitions, and collaboration are some other strategies opted for by a lot of market players.
Top Players in the Global Tissue Diagnostics Market
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Danaher Corporation (US)
- PHC Holdings Corporation (Japan)
- Thermo Fisher Scientific Inc. (US)
- Abbott (US)
- Agilent Technologies, Inc. (US)
- Merck KGaA (Germany)
- Sakura Finetek Japan Co., Ltd. (Japan)
- Abcam Plc (UK)
- Becton, Dickinson and Company (US)
- Bio SB (US)
- BioGenex (US)
- Cell Signaling Technology, Inc. (US)
- Histo-Line Laboratories (Italy)
- Slee Medical GmbH (Germany)
- CellPath Ltd. (UK)
- Amos Scientific Pty Ltd. (Australia)
- Jinhua Yidi Medical Appliance Co., Ltd. (China)
- Medite Medical GmbH (Germany)
- Diapath S.p.A. (Italy)
Tissue Diagnostics Market Recent Developments
- In May 2021, Discovery Life Sciences, a global biospecimen, and biomarker-specialists company has announced to acquire Targos Molecular Pathology GmbH, A Germany based molecular pathology laboratory. This acquisition is mainly aimed towards expansion of Discovery Life Science services, making it a global provider for biomarker development, and clinical trial support.
- In May 2021, Roche Diagnostics, a sub-division of the Hoffmann-La Roche Ltd. Announced its partnership with Canadian Blood Services, a Canadian based non-profit organization to expand the study immune response to SARS-CoV-2.
Tissue Diagnostics Key Market Trends
- Transition Towards Customized Healthcare: Growing trend in tissue diagnostics toward personalized therapy, where the increasing demand for appropriate diagnostic tools to point toward the specific markers is witnessed with the focus by the medical professionals on tailoring the therapy for each patient according to their individual genetic makeup. This approach is very much dependent on tissue diagnostics making detailed characterization of tumors and diseases feasible. The development in genetic profiling and molecular diagnostics is aiding the building of more customized therapies. In doing so, it improves the patient’s condition. It is giving impetus to innovation in tissue diagnostics technology as interested parties want to provide more personalized and efficient treatment alternatives.
- Digital Pathology Integration: Digital pathology is significantly shaping the market for tissue diagnostics to a quite large measure. Digital pathology uses digital images for diagnosis, instead of the traditional glass slides, thereby allowing access, better cooperation, and more efficient processes. This technology enables pathologists to detect diseases with higher precision by the application of artificial intelligence coupled with contemporary picture analysis. As healthcare professionals are now increasingly educated about advantages such as quicker turnaround times and efficiency, digital pathology is poised to gain greater adoption. This would set a pattern for the change to more integrated healthcare systems and better diagnostic processes.
Tissue Diagnostics Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, an increase in trends toward customized therapy, rising prevalence of chronic diseases, and technical improvements bring a sharp rise in the tissue diagnostics market. A growing emphasis on speedy and accurate diagnosis by healthcare providers stimulates demand for advanced technologies, such as digital pathology and superior imaging techniques. However, before the industry becomes what it has the potential to be, there are inefficient barriers that must break down those being cost and red tape. As stakeholders increasingly utilize innovative technology and personalized approaches to improve diagnosis accuracy and the effectiveness of treatment, tissue diagnostics has tremendous potential in the future for enhancing patient outcomes.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 5.3 Billion |
| Market size value in 2032 | USD 10.04 Billion |
| Growth Rate | 6.6% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Tissue Diagnostics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Tissue Diagnostics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Tissue Diagnostics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Tissue Diagnostics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Tissue Diagnostics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Tissue Diagnostics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
